Harm Reduction Services
1. Opioid Substitution Treatment Service
- OST Service Specification
- Service User and Provider Agreement (Generic)
- Belfast HSC Trust "Substitute Prescribing Agreement"
- Oromucosal Buprenorphine : Espranor®
- References
- Opioid Substitution Treatment : Northern Ireland Supplementary Guidance for Community Pharmacists 2019 (Version 1.1) Updated January 2021
- Opioid Substitution Treatment : Cover letter issued with Northern Ireland Supplementary Guidance for Community Pharmacists 2019 (July 2019)
- Drug Misuse and Dependence : UK Guidelines on Clinical Management 2017
- Learning from Serious Adverse Incident (SAI) : Action Required when a Patient Receiving Oral Substitution Treatment (OST) Misses Doses or Circumstances Change (Jan 2021)
- Opioid Substitution Treatment : Addendum to NI Supplementary Guidance for Community Pharmacists 2019 (Jan 2021)
2. Needle and Syringe Exchange Service
- NSES Service Specification (2022)
- List of Community Pharmacy Providers 2022
- Low Threshold Services (2017)
- Needle and Syringe Provision : Self Select Order Form (PHA,2022)
- NI Guide to Needle Exchange Pack Contents
- NI Harm Reduction Information System (HRIS) Staff Member User Guide
- HRIS Paper Form
- NSES Privacy Notice
- NSES Contract
- References
3.Naloxone
- References
- "Widening the availability of Naloxone" Guidance 2017
2. Take Home Naloxone
http://www.publichealth.hscni.net/publications/take-home-naloxone